A phase II trial of ifosfamide, methotrexate, etoposide, and prednisolone (IMEP) for previously untreated stage I, II extranodal natural killer/T-cell lymphoma, nasal type (NTCL): A multicenter study of the Korean Cancer Study Group.
Tae Min Kim
No relevant relationships to disclose
Dong-Wan Kim
No relevant relationships to disclose
Yoon-Koo Kang
No relevant relationships to disclose
Goon Jae Cho
No relevant relationships to disclose
Hong-Suk Song
No relevant relationships to disclose
Hyo Jung Kim
No relevant relationships to disclose
Byung Soo Kim
No relevant relationships to disclose
Jong-Seok Lee
No relevant relationships to disclose
Hawk Kim
No relevant relationships to disclose
Sung Hyun Yang
No relevant relationships to disclose
Young Jin Yuh
No relevant relationships to disclose
Sung Hwa Bae
No relevant relationships to disclose
Kyung-Hee Lee
No relevant relationships to disclose
Yoon-Kyung Jeon
No relevant relationships to disclose
Chul Woo Kim
No relevant relationships to disclose
Dae Seog Heo
No relevant relationships to disclose